Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia

Duman, Neval; UYANIK, Abdullah; Unsal, Abdulkadir; Sezer, Siren; ÇAMSARI, TANER; Cirit, Mustafa; YILMAZ, MEHMET; ALTUN, BÜLENT; Duranay, Murat; Yildiz, Alaattin; ŞAHİN, İDRİS; DOĞUKAN, AYHAN; ÜSTÜNDAĞ, SEDAT; KARAYAYLALI, İBRAHİM; VELİOĞLU, ARZU; Sindel, Sukru; KIYKIM, AHMET; YENİÇERİOĞLU, YAVUZ; Akbas, Ertugrul; Ozdener, Fatih

doi:10.1093/ckj/sfu079

Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia

Atıf İçin Kopyala

Duman N., UYANIK A., Unsal A., Sezer S., ÇAMSARI T., Cirit M., ...Daha Fazla

CLINICAL KIDNEY JOURNAL, cilt.7, sa.5, 2014 (ESCI)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 7 Sayı: 5
Basım Tarihi: 2014
Doi Numarası: 10.1093/ckj/sfu079
Dergi Adı: CLINICAL KIDNEY JOURNAL
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
Hacettepe Üniversitesi Adresli: Evet

Özet

Background. This study was conducted to evaluate the efficacy and safety of once-monthly continuous erythropoietin receptor activator (CERA) for maintenance of stable haemoglobin (Hb) levels in adult chronic renal anaemia patients on dialysis according to local clinical judgment in Turkey.